Related by context. Frequent words. (Click for all words.) 71 Initiates Phase II 71 leading lipid nanoparticle 70 R sorafenib tablets 70 ZFP Therapeutics 70 novel RNAi therapeutics 69 Idera Pharmaceuticals 69 Panzem R 68 Rosetta dependence 68 Exploit collaboration 68 NV Organon 68 Panzem R NCD 67 HepeX B 67 JAK inhibitor 67 Syntonix 67 TOCOSOL Paclitaxel 67 developing Zerenex TM 67 Vaccinex 66 novel antibody therapeutics 66 Presents Positive 66 refractory chronic lymphocytic 66 Nanobody 66 StromaCel Inc. 66 HCV protease inhibitor 66 FACTIVE R gemifloxacin 66 elotuzumab 66 deforolimus 66 Inc Therapeutic Competitors 66 SAR# [004] 66 epothilone 65 inflammatory autoimmune diseases 65 vosaroxin 65 Copegus R 65 Receives Orphan Drug Designation 65 Pharmion Corporation 65 optical biosensors 65 Ibis Biosciences 65 unique PER.C6 ® 65 Kuvan R 65 Sangamo ZFP technology 65 Nasdaq CRXL 65 Taiho Pharmaceutical 65 2 methoxyestradiol 65 Factor VIIa 65 liposomal formulation 65 BioSante licensees 65 Agios Pharmaceuticals 65 www.vivus.com 65 GVAX R 65 ALN TTR 65 Entereg R 65 concerning CombinatoRx 64 Crucell NV Euronext 64 inhaled formulation 64 PLK1 SNALP 64 please visit http:/www.supergen.com 64 UltiMAb R technology 64 CPL Biologicals 64 Hybridon 64 Vivecon 64 personalized immunotherapy 64 Meets Primary Endpoint 64 Shigamabs ® 64 Lung Rx 64 VEGFR2 inhibitor 64 Nasdaq ENZN 64 CMV vaccine 64 interferon gamma 1b 64 drug conjugate 64 non nucleoside polymerase 64 Ligand proprietary 64 Currently RegeneRx 64 Phase Ib clinical trials 64 Daclizumab 64 Pimavanserin 64 ALN TTR# 64 AzaSite Plus 64 Romidepsin 64 TSX VENTURE IMV 64 Trofex 64 Phase Ib II 64 CureDM 64 UVIDEM 64 Ramoplanin 64 Takeda Kyowa Hakko Kirin 64 Phase IIb clinical trials 64 NASDAQ CRXL 63 topical anti infective 63 epothilones 63 addressing idiopathic pulmonary 63 Ixempra 63 Bicifadine 63 drug conjugate ADC 63 HGS ETR2 63 Co BMY 63 CDP# 63 dacetuzumab 63 KNS # 63 Intarcia 63 nicotinic alpha 7 63 TELINTRA 63 Argatroban